Fundraising Fox

Nusano

West Valley City, US · 6 known investors

Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.

Founders & leadership

HCHoward C. Lewin
Howard C. LewininCo-founder & Chief Product Development Officer
GBGlenn B. Rosenthal
Glenn B. RosenthalinCo-founder & Chief Technology Officer

Investors · 6

Also in the syndicate · 3

BrightEdgeThe Wasatch GroupleadVerily

Funding

SEC filings, press & company announcements

$115M disclosed across 1 of 2 rounds · 2023–2024

  • $115MSeries COct 2024 · 2 sources

    The Wasatch Group (lead), BrightEdge, S32, Verily

    Source ↗
  • Undisclosed amountseed funding roundJan 2023
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does Nusano do?
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.
Who founded Nusano?
Nusano was founded by Howard C. Lewin, Glenn B. Rosenthal.
Who are Nusano's investors?
Nusano's investors include Wasatch Equity Partners, Section 32, S32.
How much funding has Nusano raised?
Nusano has disclosed $115M raised across 1 of its 2 known rounds.
Where is Nusano headquartered?
Nusano is headquartered in West Valley City, US.